The GNPS Drug Library may be more broadly applicable for drug screening across diverse research disciplines, such as food and environmental monitoring.
Abivax receives a "Strong Buy" rating, driven by positive phase 3 ABTECT induction data for obefazimod in moderate-to-severe ...
New findings out of King’s College London suggest that certain fiber-rich foods may help improve motility, soften stool, and ...
TipRanks on MSN
SinoMab’s SM17 IND application for IBD accepted by NMPA
An update from SinoMab Bioscience Ltd. ( ($HK:3681) ) is now available. SinoMab BioScience Limited announced that its Investigational New Drug ...
Wellbeing Whisper on MSN
Hidden dangers of GLP‑1 weight‑loss drugs you need to know
What if the race to get thin was quietly putting health at risk? That question is becoming harder to ignore as glucagon‑like ...
This article explores how beliefs and emotions shape experience and offers five science-based practices to help readers use ...
3don MSN
Microbial molecule that disarms inflammation discovered, offering new diabetes treatment strategy
An international research team has uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a ...
Discusses ASH Conference Data Updates and Portfolio Progress Including Anemia and Iron Restriction Programs December 7, 2025 ...
Leon Bellan, associate professor of mechanical and biomedical engineering at Vanderbilt, and his team have developed a novel ...
Concomitant IBD reduces disease control and treatment response among patients with PsA receiving biologic therapy.
Interactions among viruses can help them succeed inside their hosts or impart vulnerabilities that make them easier to treat.
Streamlined pharmacologic recommendations challenge the stepwise approach for moderately to severely active disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results